Posted on April 6th, 2026.

 

Depression often stays heavy even when you take the pills your doctor gives you. You might spend months or years switching from one bottle to another, waiting for a change that never comes.

 

This happens because most standard pills work on the same few parts of the brain, and if those parts are not the problem, you stay stuck in the dark. Spravato offers a different path because it uses a nasal spray to target brain areas that traditional tablets simply cannot reach.

 

Because Spravato is a powerful medication that can change how you feel in just a few minutes, the medical world has many rules about who can have it and where they can take it.

 

You cannot just buy it and take it at home while you watch television. This creates a gap between wanting to feel better and actually sitting in the clinic chair for your first dose.

 

By looking at how the referral works, you can see exactly what you need to do to get started. 

 

Grasping the Eligibility Requirements for Esketamine

Qualifying for this treatment depends on a specific diagnosis known as treatment-resistant depression or TRD. Most insurance companies and clinical guidelines define this as a situation where a patient has tried at least two different classes of antidepressant medications at an adequate dose and for a sufficient period without seeing a significant reduction in symptoms.

 

Traditional medications like SSRIs or SNRIs work on serotonin and norepinephrine, but for some people, these pathways do not provide the necessary relief. Spravato works differently by interacting with the NMDA receptors in the glutamate system, which helps repair connections in brain regions affected by long-term mood disorders.

 

Clinicians verify that a patient is currently taking an oral antidepressant before adding the nasal spray to the treatment plan. This combination approach helps maintain the progress made during the acute phase of treatment.

 

Medical history acts as the primary filter for who can safely begin the protocol. Doctors look for any history of vascular disease, such as aneurysms or high blood pressure, because the medication can cause a temporary spike in blood pressure during administration.

 

Individuals with a history of psychosis or certain substance use disorders may also need a more specialized review to verify that this treatment is the safest path forward. Providing a complete list of all past medications, including how long they were taken and why they were stopped, speeds up the approval process significantly. The goal of the intake is to verify that the patient’s biological profile aligns with how the drug interacts with the body.

 

Clinicians use several data points to determine if a patient meets the criteria for this specific intervention:

• Documentation of at least two failed antidepressant trials from different drug classes
• A current diagnosis of Major Depressive Disorder (MDD) verified by a specialist
• Evidence that previous medications were taken for at least six to eight weeks each
• A review of current oral medications that will be taken alongside the nasal spray
• A physical health screening focusing on cardiovascular stability and blood pressure
• An assessment of any history regarding liver function or respiratory issues
• A psychiatric evaluation to rule out conditions like bipolar mania or active psychosis

Meeting these requirements allows the clinical team to move forward with confidence in the safety of the plan. If a person has only tried one medication or has not stayed on a dose long enough to see an effect, the doctor might suggest another trial of a traditional pill before moving to esketamine.

 

Navigating the Referral and Insurance Steps

The formal process begins when a primary psychiatrist or a general practitioner submits a referral to a certified treatment center. Because this medication is part of a Risk Evaluation and Mitigation Strategy (REMS) program, it cannot be self-administered at home. The referring doctor must provide detailed clinical notes that prove the patient meets the TRD criteria mentioned previously.

 

Insurance companies often require a prior authorization, which involves a line-by-line review of the patient's medical record to confirm that all other options have been exhausted. This step can take anywhere from a few days to several weeks depending on the clarity of the documentation provided by the referring office.

 

Once the referral is received, the specialty clinic enrolls the patient in the national REMS database. This system tracks every dose of the medication to prevent misuse and to monitor for long-term safety across all patients. During this time, the clinic's administrative staff works closely with the patient's insurance provider to determine the cost of the medication and the associated observation fees.

 

Patients should expect to receive a phone call or an email regarding their benefit coverage and any potential out-of-pocket costs before the first session is scheduled. Having all insurance cards and contact information for past doctors ready helps this phase move along without unnecessary pauses.

 

Proper documentation is the most frequent cause of delay in the referral pipeline, so keeping organized records is helpful:

• Clinical notes from the last two years of psychiatric care
• A list of all pharmacies used to fill past mental health prescriptions
• Detailed reports of any side effects experienced with previous antidepressants
• Current contact information for the referring physician and any therapists
• A copy of recent lab work or physical exam results if requested
• Insurance policy numbers and secondary coverage information
• A signed release of information form allowing the two offices to communicate

Coordination between the referring doctor and the treatment center makes certain that the care remains consistent. The specialist clinic does not usually take over the entire management of the patient's mental health; instead, they function as a partner for this specific procedure.

 

Clear communication between these two entities prevents medication conflicts and allows for better tracking of the patient's progress over time. This collaborative model creates a safety net that supports the patient from multiple angles throughout the duration of the treatment.

 

Preparing for the Clinical Consultation

The final step before the first dose is a face-to-face consultation at the specialty clinic. This meeting allows the presiding medical professional to perform a physical check and a final psychiatric review. During this visit, the provider explains the logistics of the two-hour observation period required after each administration.

 

Patients must agree to a safety plan that includes having a designated driver to take them home after every session. Because the medication can cause temporary sedation or dissociative effects, driving or operating heavy machinery is strictly prohibited for the remainder of the treatment day.

 

Practitioners also use this time to talk about what the sensation of the medication feels like. Some people experience a feeling of "floating" or changes in how they perceive light and sound shortly after the nasal spray is used. Learning what to expect during the two-hour window helps reduce anxiety and allows the patient to relax into the therapeutic environment.

 

The clinic staff will check blood pressure before, during, and after the session to make certain the body is reacting well to the dose. These sessions usually occur twice a week for the first month, then transition to once a week, and eventually to a maintenance schedule based on how the patient responds.

 

Practical preparations for the first visit and subsequent sessions help make the experience more comfortable:

• Arranging for a reliable ride to and from the clinic for every appointment
• Bringing headphones or a book to stay occupied during the two-hour wait
• Wearing comfortable clothing that allows for easy blood pressure monitoring
• Avoiding heavy meals for at least two hours before the appointment to prevent nausea
• Staying hydrated throughout the day prior to arriving at the clinic
• Clearing the rest of the day’s schedule to allow for rest after the session
• Preparing a list of current symptoms or changes to discuss with the nurse

Success with this treatment involves staying consistent with the scheduled appointments. Missing sessions during the initial ramp-up phase can hinder the effectiveness of the medication and may require the patient to restart the induction process.

 

The clinical team monitors the patient's mood using standardized scales at every visit to determine if the dosage needs adjustment. This data-driven approach allows for a highly personalized experience that adapts to the specific needs of the individual as they move toward better health.

 

Related: Strategies To Manage Superwoman Syndrome And Prevent Burnout

 

Moving Forward with Specialized Care

Lifespan Collaborative Services focuses on providing a structured and supportive environment for those navigating the complexities of mental health treatment. Our team prioritizes clear communication and thorough clinical evaluations to help every individual find the most appropriate care path.

 

Our clinic offers Spravato administration as part of a comprehensive strategy for managing treatment-resistant depression. We guide patients through the REMS enrollment and work to verify that all safety protocols are followed with the highest level of professional care.

 

If standard medications have not provided the relief you need, we can evaluate if this nasal spray protocol is the right addition to your current mental health plan. Schedule a consultation with Lifespan Collaborative Services to determine if this innovative therapy is right for you.

 

Feel empowered to reach out to our team at [email protected] or by calling us at (203) 463-4555.